Skip to main
CERT

Certara (CERT) Stock Forecast & Price Target

Certara (CERT) Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 0%
Buy 38%
Hold 63%
Sell 0%
Strong Sell 0%

Bulls say

Certara is likely to continue to accelerate medicines to patients using biosimulation software and technology, which could drive significant time and cost savings in drug discovery and development. The company has a strong presence in key markets and has reported strong production results, indicating success in its CIL and heap-leach circuits. Additionally, its recent divestiture of R&MW and focus on MIDD and AI-platform investments could contribute to improved growth and margin profiles for the company. While there are potential challenges such as competition and regulatory factors, Certara's strategic direction and potential catalysts, like the planned regional consolidation and drill program for its MDN project, support a positive outlook for the company.

Bears say

Certara is facing some challenges in achieving sustainable growth and improved profitability, as its near-term performance is highly dependent on the success of ramping growth and margin recovery in the second half of 2026. Additionally, concerns remain around the company's ability to drive consistent services revenue, and continued struggles in the Asian market may impact overall revenue growth. There is also the risk of passive selling pressure from potential removal from small-cap market indexes, which could negatively affect the company's stock value.

Certara (CERT) has been analyzed by 8 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 38% recommend Buy, 63% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Certara and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Certara (CERT) Forecast

Analysts have given Certara (CERT) a Hold based on their latest research and market trends.

According to 8 analysts, Certara (CERT) has a Hold consensus rating as of Sep 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $8.44, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $8.44, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Certara (CERT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.